Background Heart failure presents a growing clinical and economic burden in the USA.
Robust cost data on the burden of illness are critical to inform economic evaluations of new …

Background Heart failure is a major and growing medical and economic problem worldwide
as 1–2% of the healthcare budget are spent for heart failure. The prevalence of heart failure …

5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Представлен анализ трех эпидемиологических исследований (ЭПОХА-ХСН, ЭПОХА-
Госпиталь-ХСН и ЭПОХА-Декомпенсация-ХСН). За 16 лет в РФ распространенность …

Aims To compare the effectiveness of transitional care services in decreasing all‐cause
death and all‐cause readmissions following hospitalization for heart failure (HF). Methods …

Background Specialised disease management programmes for heart failure aim to improve
care, clinical outcomes and/or reduce healthcare utilisation. Since the last version of this …

Background Heart failure (HF) imposes both direct costs to healthcare systems and indirect
costs to society through morbidity, unpaid care costs, premature mortality and lost …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Heart failure (HF) is a major public health issue, with a prevalence of over 5.8 million in the
USA, and over 23 million worldwide, and rising. The lifetime risk of developing HF is one in …

ESC Guidelines 2389 disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing …